PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Pfizer
Pfizer
Takeda
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
3B Pharmaceuticals GmbH
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
Hutchmed
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Inhibrx Biosciences, Inc
Fusion Pharmaceuticals Inc.
Ipsen
Merck Sharp & Dohme LLC
Fate Therapeutics
Seagen Inc.
CureOne